Asimadoline — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms
Phase 2 · Vasomotor Symptoms |
Tioga Pharmaceuticals | Asimadoline |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|